Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma

Neurology. 2009 Nov 3;73(18):1509-10. doi: 10.1212/WNL.0b013e3181bf9907.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Central Nervous System Neoplasms / diagnosis
  • Central Nervous System Neoplasms / genetics*
  • Central Nervous System Neoplasms / metabolism
  • DNA Methylation*
  • Female
  • Glioblastoma / diagnosis
  • Glioblastoma / genetics*
  • Glioblastoma / metabolism
  • Humans
  • Male
  • O(6)-Methylguanine-DNA Methyltransferase / genetics*
  • O(6)-Methylguanine-DNA Methyltransferase / metabolism
  • Predictive Value of Tests
  • Prognosis

Substances

  • Biomarkers, Tumor
  • O(6)-Methylguanine-DNA Methyltransferase